Wu, T., Ke, Y., Tang, H., Liao, C., Li, J., & Wang, L. (2021). Fidarestat induces glycolysis of NK cells through decreasing AKR1B10 expression to inhibit hepatocellular carcinoma. Elsevier.
Chicago Style (17th ed.) CitationWu, Tiangen, Yang Ke, Haoran Tang, Chen Liao, Jinze Li, and Lin Wang. Fidarestat Induces Glycolysis of NK Cells Through Decreasing AKR1B10 Expression to Inhibit Hepatocellular Carcinoma. Elsevier, 2021.
MLA (8th ed.) CitationWu, Tiangen, et al. Fidarestat Induces Glycolysis of NK Cells Through Decreasing AKR1B10 Expression to Inhibit Hepatocellular Carcinoma. Elsevier, 2021.
Warning: These citations may not always be 100% accurate.